Report overview
This report aims to provide a comprehensive presentation of the global market for Ocular Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Drug Delivery. This report contains market size and forecasts of Ocular Drug Delivery in global, including the following market information:
Global Ocular Drug Delivery Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Ocular Drug Delivery Market Sales, 2018-2023, 2024-2030, (K Doses)
Global top five Ocular Drug Delivery companies in 2022 (%)
The global Ocular Drug Delivery market was valued at US$ 25380 million in 2022 and is projected to reach US$ 34760 million by 2030, at a CAGR of 4.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Ocular Insert Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Ocular Drug Delivery include OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside Biomedical, Graybug Vision Inc and Taiwan Liposome Company, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ocular Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ocular Drug Delivery Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Doses)
Global Ocular Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Ocular Insert
Iontophoresis
Intraocular Implants
In Situ Gel & Punctal Plugs
Others
Global Ocular Drug Delivery Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Doses)
Global Ocular Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings
Global Ocular Drug Delivery Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Doses)
Global Ocular Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ocular Drug Delivery revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Ocular Drug Delivery revenues share in global market, 2022 (%)
Key companies Ocular Drug Delivery sales in global market, 2018-2023 (Estimated), (K Doses)
Key companies Ocular Drug Delivery sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ocular Drug Delivery, market overview.
Chapter 2: Global Ocular Drug Delivery market size in revenue and volume.
Chapter 3: Detailed analysis of Ocular Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ocular Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ocular Drug Delivery capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
